<DOC>
	<DOCNO>NCT01386645</DOCNO>
	<brief_summary>The study determine increase high low blood glucose level ( glycemic variability ) impair insulin secretion people impair glucose tolerance and/or impair fast glucose risk develop type 2 diabetes . Furthermore , study determine whether change beta-cell function associate glycemic variability whether mediate oxidative stress . To decrease increase glycemic variability study provide subject special diet contain either low high glycemic index food respectively 4 week . To determine oxidative stress mediator , subject high glycemic index diet take either placebo anti-oxidant N-acetylcysteine . The study address hypothesis increase glycemic variability result increase oxidative stress thereby exacerbate beta-cell dysfunction individual impair glucose tolerance and/or impair fast glucose . The finding may important implication development effective strategy aim prevention treatment type 2 diabetes . In addition , understand contribution dietary glycemic index beta-cell dysfunction subject pre-diabetes may significant public health impact , include change dietary counseling promotion healthier eating pattern .</brief_summary>
	<brief_title>Effect Dietary Glycemic Index Beta-cell Function</brief_title>
	<detailed_description>Type 2 diabetes major health problem United States affect million people . It cause failure pancreatic beta-cells secrete enough insulin result high blood glucose level . People impair glucose tolerance ( IGT ) impair fast glucose elevate glucose level increase risk progress type 2 diabetes . The long-term objective research well understand factor contribute loss beta-cell function impair insulin secretion . High glucose level show impair beta-cell function cause oxidative stress , oscillate high glucose level increase oxidative stress even continuous high glucose . Diets contain food high glycemic index ( GI ) increase glycemic load ( GL ) diet post-prandial glucose level . Therefore , high GL ( HGL ) diet could potentially damaging beta-cell increase glucose fluctuation oxidative stress . Conversely , low GL ( LGL ) diet may beneficial . The study explore hypothesis increase glycemic variability result increase oxidative stress thereby exacerbate beta-cell dysfunction people pre-diabetes . Specific Aim 1 : Determine HGL diet worsens LGL diet improve beta-cell function compare baseline control diet subject pre-diabetes . Specific Aim 2 : Determine increase glycemic variability HGL diet associate decrease beta-cell function conversely decreased glycemic variability LGL diet associate improved beta-cell function subject pre-diabetes . Specific Aim 3 : Determine oxidative stress induce HGL diet mediates decrease beta-cell function determine 1 ) systemic marker oxidative stress associate beta-cell function ; 2 ) relationship glycemic variability beta-cell function least partially explain oxidative stress ; 3 ) anti-oxidant N-acetylcysteine ( NAC ) prevent decrease beta-cell function HGL diet . Study design : The study randomize , parallel-design feeding study men woman pre-diabetes . Subjects randomly assign one 3 separate arm ( n=20/arm ) : 1 ) 4 week LGL diet ( GI &lt; 35 ) ; 2 ) 4 week HGL diet ( GI &gt; 70 ) + placebo twice daily ; 3 ) 4 week HGL diet ( GI &gt; 70 ) + NAC 1200 mg twice daily . Subjects study 2 week baseline control diet moderate glycemic load ( GI 55-58 ) comparison diet weight stable macronutrient composition ( 55 % carbohydrate/30 % fat/15 % protein ) . Beta-cell function assess frequently sample intravenous glucose tolerance test meal test . Glycemic variability assess Continuous Glucose Monitoring System glycemic control fructosamine . Markers oxidative stress measure .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>impaired glucose tolerance ( 2 hour glucose 140200 mg/dl standard 75 grams oral glucose tolerance test [ OGTT ] ) fast glucose 100115 mg/dl 2 hour glucose &gt; 100 mg/dl standard OGTT diabetes take diabetes medication fast glucose &gt; 115 mg/dl alanine aminotransferase ( ALT ) &gt; 1.5 time upper limit normal hematocrit &lt; 33 % serum creatinine &gt; 1.5 men &gt; 1.3 woman multiple food allergy intolerances serious medical inflammatory condition pregnancy lactation smoke use tobacco take medication affect insulin sensitivity secretion ( niacin , diabetes medication glucocorticoid ) inflammation ( antiinflammatories ibuprofen , naprosyn , aspirin ) significant gastroesophageal reflux ( heartburn ) , swallow problem stomach ulcer , include take medication indication take take another investigational drug within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>impaired glucose tolerance</keyword>
	<keyword>prediabetes</keyword>
	<keyword>dietary glycemic index</keyword>
	<keyword>beta-cell function</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>glycemic variability</keyword>
</DOC>